Paper32059697
Better influenza vaccines: an industry perspective.
Chen JR and 3 others. J Biomed Sci, 2020. Cited by 107 papers, by iCite.
Cite this record
ConductScience Library. Better influenza vaccines: an industry perspective. Papers, record 32059697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32059697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycoproteins | Major topic |
| Immunogenicity, Vaccine | Major topic |
| Influenza Vaccines | Major topic |
| Protein Engineering | Major topic |
| Viral Proteins | Major topic |
| Glycosylation | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AS-SUMMIT-108 | Academic Sinica Genomics Research Center Summit Project | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7966893 | The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. | JAMA | 1994 | https://conductscience.org/library/papers/7966893 | PubMed |
| 2 | 29643370 | How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin. | Nat Commun | 2018 | https://conductscience.org/library/papers/29643370 | PubMed |
| 3 | 19465683 | Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. | Science | 2009 | https://conductscience.org/library/papers/19465683 | PubMed |
| 4 | 26439108 | A review of the changes to the licensing of influenza vaccines in Europe. | Influenza Other Respir Viruses | 2016 | https://conductscience.org/library/papers/26439108 | PubMed |
| 5 | 26119736 | Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. | Cell Rep | 2015 | https://conductscience.org/library/papers/26119736 | PubMed |
| 6 | 9060710 | Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. | J Virol | 1997 | https://conductscience.org/library/papers/9060710 | PubMed |
| 7 | 29506129 | A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29506129 | PubMed |
| 8 | 24595369 | Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family. | mBio | 2014 | https://conductscience.org/library/papers/24595369 | PubMed |
| 9 | 12660783 | Ecological and immunological determinants of influenza evolution. | Nature | 2003 | https://conductscience.org/library/papers/12660783 | PubMed |
| 10 | 3016304 | Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. | J Virol | 1986 | https://conductscience.org/library/papers/3016304 | PubMed |
| 11 | 4717617 | Control of influenza. | Med J Aust | 1973 | https://conductscience.org/library/papers/4717617 | PubMed |
| 12 | 28636855 | Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28636855 | PubMed |
| 13 | 29479277 | Intranasal influenza vaccine: Why does Canada have different recommendations from the USA on its use? | Paediatr Child Health | 2018 | https://conductscience.org/library/papers/29479277 | PubMed |
| 14 | 29100705 | Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine. | Vaccine | 2018 | https://conductscience.org/library/papers/29100705 | PubMed |
| 15 | 20878593 | DNA-based influenza vaccines: evaluating their potential to provide universal protection. | IDrugs | 2010 | https://conductscience.org/library/papers/20878593 | PubMed |
| 16 | 21846636 | Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21846636 | PubMed |
| 17 | 21506635 | ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation. | Expert Rev Vaccines | 2011 | https://conductscience.org/library/papers/21506635 | PubMed |
| 18 | 24469815 | Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24469815 | PubMed |
| 19 | 30782805 | Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30782805 | PubMed |
| 20 | 22286307 | Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. | Nat Med | 2012 | https://conductscience.org/library/papers/22286307 | PubMed |
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 107 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42295617 | mRNA Vaccines for Influenza: Hope for a Universal Vaccine? | BioDrugs | 2026 | https://conductscience.org/library/papers/42295617 | PubMed |
| 42198750 | Hypoxia-Enhanced N110 Glycosylation of Hemagglutinin Promotes H3N2 Influenza Virus Fitness by Modulating Receptor Binding and Immune Evasion. | Viruses | 2026 | https://conductscience.org/library/papers/42198750 | PubMed |
| 42081324 | Enhanced immunogenicity and dose-sparing efficacy of self-amplifying RNA vaccines against seasonal influenza across subtypes. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42081324 | PubMed |
| 41917410 | The Biological Role of Enveloped Virus Glycosylation and Its Interactions with Antiviral Lectins. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41917410 | PubMed |
| 41795070 | Genomic surveillance of H1N1, H3N2 and influenza B Victoria lineage viruses in Qingyang (2020-2023): phylogenetic and molecular characteristics analysis of HA/NA genes. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41795070 | PubMed |
| 41712567 | Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets. | PLoS One | 2026 | https://conductscience.org/library/papers/41712567 | PubMed |
| 41618423 | The nanoemulsion adjuvant provides antigen dose-sparing effects and enhances maternal passive immune protection for the cell-cultured quadrivalent influenza virus subunit vaccine. | Virol J | 2026 | https://conductscience.org/library/papers/41618423 | PubMed |
| 41600688 | Molecular Characterization of an H3N2 Canine Influenza Virus Isolated from a Dog in Jiangsu, China, in 2025. | Vet Sci | 2025 | https://conductscience.org/library/papers/41600688 | PubMed |
| 41520499 | Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone. | Virology | 2026 | https://conductscience.org/library/papers/41520499 | PubMed |
| 41279549 | Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279549 | PubMed |
| 41235250 | A DNA vaccine based on hemagglutinin and conserved epitopes of influenza B virus provides cross-lineage protection in mice. | Front Immunol | 2025 | https://conductscience.org/library/papers/41235250 | PubMed |
| 41156761 | Epidemiological Shifts in Respiratory Virus Infections Among Older Adults (≥65 Years) Before and After the COVID-19 Pandemic: An 18-Year Retrospective Study in the Republic of Korea. | Microorganisms | 2025 | https://conductscience.org/library/papers/41156761 | PubMed |
| 41082385 | Beyond alarmism: what Australia's influenza season really tells us about Italy. | Pathog Glob Health | 2026 | https://conductscience.org/library/papers/41082385 | PubMed |
| 41042449 | Superior Effectiveness and Estimated Public Health Impact of Cell- Versus Egg-Based Influenza Vaccines in Children and Adults During the US 2023-2024 Season. | Infect Dis Ther | 2025 | https://conductscience.org/library/papers/41042449 | PubMed |
| 40909923 | Co-injection with inactivated Enterococcus faecium and inactivated H1N1 influenza virus intravenously strengthen the protection of H1N1 influenza virus infections in mice. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40909923 | PubMed |
| 40872906 | Advancing Reversed-Phase Chromatography Analytics of Influenza Vaccines Using Machine Learning Approaches on a Diverse Range of Antigens and Formulations. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40872906 | PubMed |
| 40796271 | Understanding off-target growth defects introduced to influenza A virus by synonymous recoding. | RNA | 2025 | https://conductscience.org/library/papers/40796271 | PubMed |
| 40733722 | Ferritin-Based HA DNA Vaccine Outperforms Conventional Designs in Inducing Protective Immunity Against Seasonal Influenza. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40733722 | PubMed |
| 40667976 | Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3.4.4b influenza virus. | J Virol | 2025 | https://conductscience.org/library/papers/40667976 | PubMed |
| 39772044 | Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39772044 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HAS1 | 3036 | PubTator's text mining | https://conductscience.org/library/genes/3036 | NCBI Gene |
| MGAT1 | 4245 | PubTator's text mining | https://conductscience.org/library/genes/4245 | NCBI Gene |
| NEU1 | 4758 | PubTator's text mining | https://conductscience.org/library/genes/4758 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32059697
GET https://conductscience.org/api/papers/v1/32059697/references?page=2